NKTR Earnings Nektar Therapeutics
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q2 2026 | 2026-06-30 | -1.23 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.82 | 2026-05-08 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -1.29 | 2026-03-13 | 10-K |
| FY 2025 | 2025-12-31 | -9.73 | 2026-03-13 | 10-K |
| Q3 2025 | 2025-09-30 | -1.87 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.95 | 2025-08-08 | 10-Q |
| Q1 2025 | 2025-03-31 | -3.62 | 2025-05-09 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 0.59 | 2025-03-14 | 10-K |
| FY 2024 | 2024-12-31 | -8.68 | 2025-03-14 | 10-K |
| Q3 2024 | 2024-09-30 | -2.66 | 2024-11-08 | 10-Q |
| Q2 2024 | 2024-06-30 | -3.76 | 2024-08-09 | 10-Q |
| Q1 2024 | 2024-03-31 | -2.85 | 2024-05-10 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -3.15 | 2024-03-05 | 10-K |
| FY 2023 | 2023-12-31 | -21.75 | 2024-03-05 | 10-K |
| Q3 2023 | 2023-09-30 | -3.60 | 2023-11-08 | 10-Q |
| Q2 2023 | 2023-06-30 | -4.05 | 2023-08-09 | 10-Q |
| Q1 2023 | 2023-03-31 | -10.95 | 2023-05-10 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -4.80 | 2023-02-28 | 10-K |
| FY 2022 | 2022-12-31 | -29.55 | 2023-02-28 | 10-K |
| Q3 2022 | 2022-09-30 | -4.65 | 2022-11-04 | 10-Q |
| Q2 2022 | 2022-06-30 | -12.75 | 2022-08-05 | 10-Q |
| Q1 2022 | 2022-03-31 | -7.35 | 2022-05-06 | 10-Q |
| Q4 2021 | 2021-12-31 | -11850.00 | 2022-03-01 | 10-K |
| FY 2021 | 2021-12-31 | -42.90 | 2022-03-01 | 10-K |
| Q3 2021 | 2021-09-30 | -10.50 | 2021-11-05 | 10-Q |
| Q2 2021 | 2021-06-30 | -10.35 | 2021-08-06 | 10-Q |
| Q1 2021 | 2021-03-31 | -10.20 | — | — |
| Q4 2020 | 2020-12-31 | -9.75 | 2021-02-26 | 10-K |
| FY 2020 | 2020-12-31 | -37.35 | 2021-02-26 | 10-K |
| Q3 2020 | 2020-09-30 | -9.15 | — | — |
| Q2 2020 | 2020-06-30 | -6.75 | — | — |
| Q1 2020 | 2020-03-31 | -11.70 | — | — |
| Q4 2019 | 2019-12-31 | -9.60 | 2020-02-28 | 10-K |
| FY 2019 | 2019-12-31 | -37.80 | 2020-02-28 | 10-K |
| Q3 2019 | 2019-09-30 | -8.40 | 2019-11-07 | 10-Q |
| Q2 2019 | 2019-06-30 | -9.45 | 2019-08-09 | 10-Q |
| Q1 2019 | 2019-03-31 | -10.35 | — | — |
| Q4 2018 | 2018-12-31 | -8.55 | 2019-03-01 | 10-K |
| FY 2018 | 2018-12-31 | 56.70 | 2019-03-01 | 10-K |
| Q3 2018 | 2018-09-30 | -8.40 | 2018-11-08 | 10-Q |
| Q2 2018 | 2018-06-30 | 79.95 | 2018-08-09 | 10-Q |
| Q1 2018 | 2018-03-31 | -9.00 | — | — |
| Q4 2017 | 2017-12-31 | -3.15 | 2018-03-01 | 10-K |
| FY 2017 | 2017-12-31 | -9.30 | — | — |
| Q3 2017 | 2017-09-30 | 5.55 | 2017-11-08 | 10-Q |
| Q2 2017 | 2017-06-30 | -5.85 | — | — |
| Q1 2017 | 2017-03-31 | -6.30 | — | — |
| Q4 2016 | 2016-12-31 | -4.20 | 2017-03-01 | 10-K |
| FY 2016 | 2016-12-31 | -16.50 | — | — |
| Q3 2016 | 2016-09-30 | -4.80 | — | — |
| Q2 2016 | 2016-06-30 | -5.40 | — | — |
| Q1 2016 | 2016-03-31 | -2.10 | 2016-05-04 | 10-Q |
| Q4 2015 | 2015-12-31 | -6.00 | 2016-02-29 | 10-K |
| Q3 2015 | 2015-09-30 | -0.90 | 2015-11-06 | 10-Q |
| Q2 2015 | 2015-06-30 | -6.00 | — | — |
| Q1 2015 | 2015-03-31 | 3.75 | 2015-05-01 | 10-Q |
| Q4 2014 | 2014-12-31 | -5.25 | 2015-02-26 | 10-K |
| Q3 2014 | 2014-09-30 | 7.95 | 2014-11-07 | 10-Q |
| Q2 2014 | 2014-06-30 | -3.90 | — | — |
| Q1 2014 | 2014-03-31 | -5.55 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.